NCT01720875View on ClinicalTrials.gov

Vorinostat, Bortezomib and Dexamethasone in Multiple Myeloma (MUKFour)

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 9, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 29, 2018

Conditions
Multiple Myeloma
Interventions
DRUG

Vorinostat Velcade Dexamethasone

Trial Locations (2)

NG5 1PB

Nottingham University Hospital, Nottingham

SO16 6YD

University Hospital Southampton, Southampton

All Listed Sponsors
collaborator

Myeloma UK

OTHER

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Leeds

OTHER

NCT01720875 - Vorinostat, Bortezomib and Dexamethasone in Multiple Myeloma (MUKFour) | Biotech Hunter | Biotech Hunter